91ÑÇÉ«´«Ã½

Journal News

Small protein plays a big role in viral battles

Anna Crysler
April 30, 2024

Extracellular vesicles, or EVs, play an important role in communication among cells. Almost all cells can release EVs, which carry content that varies according to the cell type. In response to viruses, immune cells will release EVs containing information that can help the body fight viral replication and infection. But what happens when a complex pathogen hijacks this system?

HIV accessory protein negative regulatory factor
Boghog/Wikimedia Commons
The HIV accessory protein negative regulatory factor, illustrated here, allows easier viral replication and spread in host cells.

Luis daSilva’s research group at the University of São Paulo in Ribeirão Preto studies the endomembrane system of cells with particular interest in the molecular mechanisms of human immunodeficiency virus, or HIV. Viruses can take advantage of this system and impair the immune system’s ability to prevent infection. Researchers have thoroughly studied and characterized HIV’s specific proteins, and they recognize HIV accessory proteins as important virulence factors for HIV-1 pathogenesis.

In in Molecular and Cellular Proteomics, the daSilva group writes about their work studying the HIV accessory protein negative regulatory factor, or Nef, in the context of EVs. Nef allows easier viral replication and spread in host cells, and it also modifies the host’s EVs. The authors investigated the impact of this manipulation by Nef through a proteomic analysis of EVs derived from lymphocytes known as T cells.

Mara Elisama da Silva Januário is the first author of the paper. “Our study unveils the influence of Nef on the protein content of EVs released from T lymphocytes, cells that play a major role in the body’s defense,” she said. “Our recent findings highlight Nef as a global modulator of EV proteome.”

Specifically, Nef downregulates proteins in EVs that are important in the body’s antiviral response to HIV-1, including interferon-induced transmembrane proteins, or IFITMs. When IFITMs are reduced in EVs, key antiviral activities are mitigated. These proteins are among several whose expression is disrupted by Nef in HIV-1 infection. 

The researchers found that Nef could modify the levels of more than 35% of the proteins identified in EVs, and among the decreased proteins were three members of the IFITM family. These proteins are pivotal in the body’s antiviral response against viruses including Zika, dengue, influenza and HIV. 

“By decoding these intricate cellular dialogues, our work contributes a small but significant piece to the broader narrative of scientific discovery surrounding HIV-1 infection, offering potential avenues for advancements in medical interventions,” da Silva Januário said.

Unraveling the biological significance of altered proteins in EVs in relation to viral infection and replication are important next steps, she said. “We anticipate that further exploration in this direction will provide valuable insights for the field, shedding light on the intricate processes influenced by Nef and contributing to a deeper understanding of the broader implications for viral dynamics.”

Enjoy reading 91ÑÇÉ«´«Ã½ Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Anna Crysler

Anna Crysler holds a B.A. in biochemistry from Albion College and is a is a Ph.D. student in bioengineering at the University of Pennsylvania. She is an 91ÑÇÉ«´«Ã½ Today volunteer contributor.

Related articles

From the journals: MCP
Meric Ozturk
From the journals: MCP
Vanshika Patel
From the journals: MCP
Krishnakoli Adhikary
From the Journals: JBC
Ken Farabaugh
From the journals: MCP
Ankita Arora

Get the latest from 91ÑÇÉ«´«Ã½ Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

An inclusive solar eclipse — with outreach
Essay

An inclusive solar eclipse — with outreach

Dec. 26, 2024

Traveling more than 150 miles with a group of neurodivergent students to have them witness a rare orbital alignment. and also teach the public about it, requires some strategic planning.

Predicting fatty liver disease from a tiny blood sample
Journal News

Predicting fatty liver disease from a tiny blood sample

Dec. 24, 2024

Obesity and being overweight aren't the only factors that contribute to liver disease. New tests can help identify who is at risk or already has the disease, even in people who are lean or have a normal weight.

An ancient animal helps scientists improve modern technology
News

An ancient animal helps scientists improve modern technology

Dec. 22, 2024

The same molecules that help tardigrades survive extreme weather can improve cryo-EM images of cellular structures and proteins, a team led by University of Wisconsin–Madison researcher Ci Ji Lim reports.

New structure gives insight into mRNA export and cancers
News

New structure gives insight into mRNA export and cancers

Dec. 21, 2024

Yi Ren’s lab at Vanderbilt has described the structure of a protein complex that sheds light on the underlying molecular mechanism of mRNA export.

Analyzing triglycerides in Americans of African ancestry
Journal News

Analyzing triglycerides in Americans of African ancestry

Dec. 19, 2024

Using the All of Us database, researchers at Vanderbilt sought a genetic reason why some patients, often underrepresented in research, could have varying levels of fat in the bloodstream.

Of yeasts and men: One-hour proteomes, 10 years apart
Journal News

Of yeasts and men: One-hour proteomes, 10 years apart

Dec. 17, 2024

To profile the human genome within an hour, the researchers used a new mass spectrometer and packed their liquid chromatography columns with very high pressure.